H-Index & Metrics Top Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology H-index 137 Citations 89,664 329 World Ranking 58 National Ranking 42
Medicine H-index 142 Citations 95,785 402 World Ranking 599 National Ranking 358

Research.com Recognitions

Awards & Achievements

2019 - Benjamin Franklin Medal, Franklin Institute

2019 - Distinguished Fellows of the American Association of Immunologists (AAI)

2018 - Albany Medical Center Prize in Medicine and Biomedical Research

2018 - Dr. Paul Janssen Award for Biomedical Research, Johnson & Johnson for pioneering a novel and effective strategy to harness the immune system for treating solid tumor cancers.

2018 - Jessie Stevenson Kovalenko Medal, US National Academy of Sciences For important medical discoveries related to the body’s immune response to tumors.

2018 - King Faisal Prize

2018 - Nobel Prize for their discovery of cancer therapy by inhibition of negative immune regulation

2017 - BBVA Foundation Frontiers of Knowledge Award

2017 - Fellow of the American Academy of Arts and Sciences

2015 - Paul Ehrlich and Ludwig Darmstaedter Prize

2014 - Breakthrough Prize in Life Sciences for the discovery of T cell checkpoint blockade as effective cancer therapy.

2014 - Canada Gairdner International Award

2014 - Louisa Gross Horwitz Prize, Columbia University

2014 - Szent-Györgyi Prize for Progress in Cancer Research, National Foundation for Cancer Research (NFCR)

2011 - AAI Lifetime Achievement Award, American Association of Immunologists

2011 - American Association of Immunologists Lifetime Achievement Award

2008 - AAI-Steinman Award for Human Immunology Research, American Association of Immunologists

2007 - Member of the National Academy of Medicine (NAM)

2006 - Fellow of the American Association for the Advancement of Science (AAAS)

1997 - Member of the National Academy of Sciences

1930 - Fellow of the American Association for the Advancement of Science (AAAS)


What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Immune system

His primary scientific interests are in Immunology, T cell, Cytotoxic T cell, Antigen and Immune system. His biological study spans a wide range of topics, including Blockade and Melanoma. The study incorporates disciplines such as Molecular biology, Tremelimumab and Cell biology in addition to T cell.

In his research on the topic of Cytotoxic T cell, FOXP3 is strongly related with CD8. His study focuses on the intersection of Antigen and fields such as Antibody with connections in the field of Nivolumab. His Immune system research incorporates themes from Mutation, Cancer and Cancer research.

His most cited work include:

  • Restoring function in exhausted CD8 T cells during chronic viral infection (2941 citations)
  • Enhancement of antitumor immunity by CTLA-4 blockade. (2458 citations)
  • The future of immune checkpoint therapy (2293 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Immunology, T cell, Immune system, Antigen and Cytotoxic T cell. His Immunology research includes elements of Cancer, Cancer research and Blockade. His T cell research includes themes of Receptor, CD8 and Cell biology.

His studies in Immune checkpoint and Immunity are all subfields of Immune system research. His Antigen study integrates concerns from other disciplines, such as Molecular biology, Antibody and Cellular differentiation. His Cytotoxic T cell study often links to related topics such as FOXP3.

He most often published in these fields:

  • Immunology (45.64%)
  • T cell (35.06%)
  • Immune system (28.94%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (19.67%)
  • Cancer research (22.63%)
  • Oncology (16.33%)

In recent papers he was focusing on the following fields of study:

James P. Allison mainly focuses on Internal medicine, Cancer research, Oncology, Immune checkpoint and Immune system. His research integrates issues of T cell, CD8 and Immunotherapy in his study of Cancer research. His work deals with themes such as Cytotoxic T cell and Antigen, which intersect with T cell.

As a member of one scientific family, James P. Allison mostly works in the field of Oncology, focusing on Ipilimumab and, on occasion, Prostate cancer. Blockade, Cancer and Immunology are the main areas of his Immune checkpoint studies. His work carried out in the field of Immune system brings together such families of science as Receptor, Antibody and Cytokine.

Between 2016 and 2021, his most popular works were:

  • Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients (1381 citations)
  • Fundamental Mechanisms of Immune Checkpoint Blockade Therapy (844 citations)
  • Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade (514 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cancer
  • Immune system

His scientific interests lie mostly in Immune checkpoint, Cancer research, Immunotherapy, Melanoma and Cancer. His studies deal with areas such as Ipilimumab and Oncology as well as Immune checkpoint. The concepts of his Cancer research study are interwoven with issues in T cell, CD8, Immune system and Cytotoxic T cell.

His T cell research integrates issues from Precision medicine, Targeted therapy and Antigen. His study in the field of CTLA-4 and T cell differentiation also crosses realms of Context. His Immunology study combines topics from a wide range of disciplines, such as Microbiome and Feces.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Top Publications

Restoring function in exhausted CD8 T cells during chronic viral infection

Daniel L. Barber;E. John Wherry;David Masopust;Baogong Zhu.
Nature (2006)

3738 Citations

Enhancement of antitumor immunity by CTLA-4 blockade.

Dana R. Leach;Matthew F. Krummel;James P. Allison.
Science (1996)

3333 Citations

The future of immune checkpoint therapy

Padmanee Sharma;James P. Allison.
Science (2015)

2853 Citations

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.

Matthew F. Krummel;James P. Allison.
Journal of Experimental Medicine (1995)

2157 Citations

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones.

Fiona A. Harding;James G. McArthur;Jane A. Gross;David H. Raulet.
Nature (1992)

2006 Citations

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

V. Gopalakrishnan;V. Gopalakrishnan;C. N. Spencer;C. N. Spencer;L. Nezi;A. Reuben.
Science (2018)

1755 Citations

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma

Michael A. Postow;Margaret K. Callahan;Margaret K. Callahan;Christopher A. Barker;Christopher A. Barker;Yoshiya Yamada;Yoshiya Yamada.
The New England Journal of Medicine (2012)

1687 Citations

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Giao Q. Phan;James C. Yang;Richard M. Sherry;Patrick Hwu.
Proceedings of the National Academy of Sciences of the United States of America (2003)

1680 Citations

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

Michael A. Curran;Welby Montalvo;Hideo Yagita;James P. Allison.
Proceedings of the National Academy of Sciences of the United States of America (2010)

1558 Citations

Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells

Sarah E. Townsend;James P. Allison.
Science (1993)

1551 Citations

Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.

If you think any of the details on this page are incorrect, let us know.

Contact us

Top Scientists Citing James P. Allison

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 240

Gordon J. Freeman

Gordon J. Freeman

Harvard University

Publications: 224

Arlene H. Sharpe

Arlene H. Sharpe

Harvard University

Publications: 208

Lieping Chen

Lieping Chen

Yale University

Publications: 167

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 148

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 137

Hideo Yagita

Hideo Yagita

Juntendo University

Publications: 135

F. Stephen Hodi

F. Stephen Hodi

Harvard University

Publications: 127

Jeffrey A. Bluestone

Jeffrey A. Bluestone

University of California, San Francisco

Publications: 116

Charles G. Drake

Charles G. Drake

Columbia University

Publications: 115

Antoni Ribas

Antoni Ribas

University of California, Los Angeles

Publications: 115

Soldano Ferrone

Soldano Ferrone

Harvard University

Publications: 112

Carl H. June

Carl H. June

University of Pennsylvania

Publications: 103

Laurence Zitvogel

Laurence Zitvogel

Institut Gustave Roussy

Publications: 103

Michael A. Postow

Michael A. Postow

Memorial Sloan Kettering Cancer Center

Publications: 100

Something went wrong. Please try again later.